Chan Henry Lee Bei Gene, Ltd. (BGNE) insider trading activity

Chan Henry Lee is SVP, General Counsel of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Feb 27, 2025, when has been sold 1,205 shares (American Depositary Shares) at a price of $275.0 per share, resulting in proceeds of $331,375. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Chan Henry Lee Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 27 2025	SELL Open market or private sale	$331,375 $275.0 p/Share	1,205 Reduced 100.0%	0 American Depositary Sh...
Feb 21 2025	SELL Open market or private sale	$310,813 $258.58 p/Share	1,202 Reduced 100.0%	0 American Depositary Sh...
Sep 30 2024	SELL Open market or private sale	$284,994 $237.1 p/Share	1,202 Reduced 100.0%	0 American Depositary Sh...
Jul 30 2024	SELL Open market or private sale	$133,915 $160.57 p/Share	834 Reduced 100.0%	0 American Depositary Sh...
Jun 17 2024	SELL Open market or private sale	$69,893 $159.21 p/Share	439 Reduced 100.0%	0 American Depositary Sh...
Jun 05 2024	BUY Grant, award, or other acquisition	-	98,085 Added 26.69%	269,399 Ordinary Shares
Jul 31 2023	SELL Open market or private sale	$171,061 $216.26 p/Share	791 Reduced 100.0%	0 American Depositary Sh...
Jun 15 2023	BUY Grant, award, or other acquisition	-	65,585 Added 26.53%	181,597 Ordinary Shares

CHL

Chan Henry Lee

SVP, General Counsel

Camana Bay, Grand Cayman, E9

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Value

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to BeiGene, Ltd.

Track Activities on BGNE

Account